ofloxacin has been researched along with nadifloxacin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, T; Kanbe, T; Kaneko, E; Shibahara, T; Shiragiku, T; Takahashi, N; Yamashita, S | 1 |
| Hayashi, K; Mitsuyama, J; Yamakawa, T | 1 |
2 other study(ies) available for ofloxacin and nadifloxacin
| Article | Year |
|---|---|
In vitro clastogenicity of optical isomers of nadifloxacin.
Topics: Animals; Anti-Infective Agents; Cell Line; Chromosome Aberrations; Cricetinae; Cricetulus; Fluoroquinolones; Mutagenicity Tests; Mutagens; Ofloxacin; Quinolizines; Stereoisomerism | 1994 |
In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
Topics: Animals; Anti-Infective Agents; Clindamycin; Colony Count, Microbial; DNA Topoisomerase IV; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gene Frequency; Genes, Bacterial; Gentamicins; Levofloxacin; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation; Ofloxacin; Quinolines; Quinolizines; Staphylococcal Skin Infections; Staphylococcus aureus; Staphylococcus epidermidis; Topoisomerase II Inhibitors | 2002 |